Korro Bio Inc jobs
7 matches, filter-driven and evidence-linked.
Filters
0 active
Remote, hybrid, onsite
State
Shift type
Weekend work
Country
Cover letter
Assessment
Salary type
Equity type
Family-building benefits
Benefit evidence
-
Research Associate/Senior Research Associate, Oligonucleotide Chemistry
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 20263w agoWhy we showed this
Description: "bio"Description: "inc"+7
Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedResearch Associate/Senior Research Associate, Oligonucleotide Chemistry 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human
-
Senior Clinical Trial Manager
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 2026posted 66 days agoWhy we showed this
Description: "inc"Description: "korro"+7
Unspecified Healthcare From the posting source - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedSenior Clinical Trial Manager 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro
-
Associate Director, Clinical Quality Assurance
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 2026posted 50 days agoWhy we showed this
Description: "bio"Description: "korro"+7
Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedAssociate Director, Clinical Quality Assurance 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.
-
Associate Director, Data Manager
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 2026posted 56 days agoWhy we showed this
Description: "korro"Description: "bio"+7
Unspecified Other - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedAssociate Director, Data Manager 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro
-
Senior Manager, Contracts Management
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 20263w agoWhy we showed this
Description: "korro"Description: "inc"+7
Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedSenior Manager, Contracts Management 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro
-
Senior Scientist, High Throughput Screening
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 2026posted 50 days agoWhy we showed this
Description: "bio"Description: "korro"+7
Unspecified Other - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedSenior Scientist, High Throughput Screening 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.
-
Associate Medical Director / Medical Director
Korro Bio Inc - 60 First St, Cambridge, MA 02141Indexed from Lever Benefit evidence checked Nov 20, 2026posted 42 days agoWhy we showed this
Description: "bio"Description: "inc"+7
Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedAssociate Medical Director / Medical Director 60 First St, Cambridge, MA 02141 Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is for Urea Cycle Disorders. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human
-
Senior Biostatistician
Krystal Biotech Inc - Location not specifiedIndexed from Jazzhr Benefit evidence checked Nov 20, 2026posted 56 days agoWhy we showed this
Title: semantic matchEmployer: "inc"+3
Unspecified Data From the posting source - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedSenior Biostatistician About Krystal Bio: At Krystal Biotech, we bring together the brightest and most eager minds to relentlessly pursue the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Founded in 2016, Krystal is distinguished in three powerful ways: science and technology using our patented gene therapy platform, innovative manufacturing supported by our commercial scale facilities, and a unique commercialization model that focuses on the patient's end-to-end experience. Krystal received U.S. FDA approval for the first and only redosable gene therapy treatment, VYJUVEK®, for the treatment of Dystrophic Epidermolysis Bullosa (DEB). Krystal continues to leverage our proprietary platform to rapidly advance a robust pipeline of investigational genetic medicines in respiratory, oncology, dermatology, and ophthalmology. Krystal is headquartered in Pittsburgh, PA, which is home to our two state-of-the-art CGMP manufacturing facilities with teams around the world and satellite offices in Switzerland, Germany, and Japan. We are a company built and run by people who care, are fearless in the face of a challenge, love the work they do, and practice the highest level of scientific integrity. As we grow, we are seeking team members that embody these values. Position Overview: We are seeking a highly motivated Senior Biostatistician to join our Clinical Development team in Pittsburgh. This role will provide broad statistical support across several clinical-stage programs, partnering with Clinical, Regulatory, and Medical along with other cross-functional teams. This individual will support study design, analysis, interpretation, and reporting throughout product lifecycles, from clinical
-
Principal Biostatistician
Precigen Inc - Germantown, MD, USIndexed from Adp Recruiting Benefit evidence checked Nov 20, 20261w agoWhy we showed this
Title: semantic matchTitle: "bio"+3
Unspecified Data From the posting source - Principal From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedPrincipal Biostatistician Germantown, MD, US Precigen (Nasdaq: PGEN) is a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization. With a strong commitment to innovation, Precigen is developing a robust pipeline of differentiated therapies utilizing the company's AdenoVerse® and UltraCAR-T® therapeutic platforms across its core focus areas of immuno-oncology, autoimmune disorders, and infectious diseases. POSITION SUMMARY: The Principal Biostatistician is the sponsor's statistical lead for all company-sponsored studies and evidence-generation activities across Clinical Development and Medical Affairs. Statistical programming and analysis are outsourced; this role owns the statistical science, from study design through interpretation, and holds CRO statistics and programming teams to sponsor standards. The role is a scientific partner to Clinical Development, Medical Affairs and Regulatory. DUTIES AND RESPONSIBILITIES: Author or approve statistical sections of protocols and amendments: objectives, estimands (ICH E9(R1)), endpoints, sample size and randomization. Author or approve statistical analysis plans and TLF shells; ensure analysis is aligned to the scientific and regulatory question. Advise on endpoint selection, adaptive and interim designs, and multiplicity strategy. Oversee CRO biostatistics and programming: SDTM/ADaM specifications, define.xml, validation approach, TLF review and delivery timelines. Contribute to statistical and programming vendor selection and scope; review change orders for statistical work. Support data monitoring committees and interim analyses, including firewalls and unblinding controls. Interpret and present results; co-author CSRs and statistical sections of regulatory documents, briefing books and responses to agency
-
Senior Biostatistician
Precigen Inc - Germantown, MD, USIndexed from Adp Recruiting Benefit evidence checked Nov 20, 20261w agoWhy we showed this
Title: semantic matchEmployer: "inc"+3
Unspecified Data From the posting source - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedSenior Biostatistician Germantown, MD, US Precigen (Nasdaq: PGEN) is a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization. With a strong commitment to innovation, Precigen is developing a robust pipeline of differentiated therapies utilizing the company's AdenoVerse® and UltraCAR-T® therapeutic platforms across its core focus areas of immuno-oncology, autoimmune disorders, and infectious diseases. POSITION SUMMARY: The Senior Biostatistician is the sponsor's statistical lead for all company-sponsored studies and evidence-generation activities across Clinical Development and Medical Affairs. Statistical programming and analysis are outsourced; this role owns the statistical science, from study design through interpretation, and holds CRO statistics and programming teams to sponsor standards. The role is a scientific partner to Clinical Development, Medical Affairs and Regulatory. DUTIES AND RESPONSIBILITIES: Author or approve statistical sections of protocols and amendments: objectives, estimands (ICH E9(R1)), endpoints, sample size and randomization. Author or approve statistical analysis plans and TLF shells; ensure analysis is aligned to the scientific and regulatory question. Advise on endpoint selection, adaptive and interim designs, and multiplicity strategy. Oversee CRO biostatistics and programming: SDTM/ADaM specifications, define.xml, validation approach, TLF review and delivery timelines. Contribute to statistical and programming vendor selection and scope; review change orders for statistical work. Support data monitoring committees and interim analyses, including firewalls and unblinding controls. Interpret and present results; co-author CSRs and statistical sections of regulatory documents, briefing books and responses to agency
-
Quality Control Analyst I
Krystal Biotech Inc - Location not specifiedIndexed from Jazzhr Benefit evidence checked Nov 20, 20263w agoWhy we showed this
Employer: semantic matchEmployer: "inc"+3
Unspecified Operations From the posting source - Mid From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedQuality Control Analyst I Quality Control Analyst / Specialist I About Krystal Bio: At Krystal Biotech, we bring together the brightest and most eager minds to relentlessly pursue the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Founded in 2016, Krystal is distinguished in three powerful ways: science and technology using our patented gene therapy platform, innovative manufacturing supported by our commercial scale facilities, and a unique commercialization model that focuses on the patient's end to end experience. Krystal received U.S. FDA approval for the first and only redosable gene therapy treatment, VYJUVEK®, for the treatment of Dystrophic Epidermolysis Bullosa (DEB). Krystal continues to leverage our proprietary platform to rapidly advance a robust pipeline of investigational genetic medicines in respiratory, oncology, dermatology, and ophthalmology. Krystal is headquartered in Pittsburgh, PA which is home to our two state-of-the-art CGMP manufacturing facilities with teams around the world and satellite offices in Switzerland, Germany, and Japan. We are a company built and run by people who care, are fearless in the face of a challenge, love the work they do, and practice the highest level of scientific integrity. As we grow, we are seeking team members that embody these values. Job Description Summary: Krystal Biotech, Inc is seeking a highly motivated Quality Control Analyst who will perform complex analytical testing for the release of drug products for clinical and commercial use. Primary Responsibilities: Finished Product testing, stability testing, and reporting of the QC results to
-
Biochemist (Purification Scale Up)
Eurofins Scientific - Indianapolis, IN, United StatesIndexed from Smartrecruiters Benefit evidence checked Nov 20, 20261w agoWhy we showed this
Title: semantic matchTitle: "bio"+2
Unspecified Other - Mid From the posting source Salary not disclosed Inferred from posting 401(k) reportedBiochemist (Purification Scale Up) Indianapolis, IN, United States Company Description: Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing and in agroscience Contract Research Organisation services. Eurofins is one of the market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development and Manufacturing Organisations. The Group also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products. In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to 55,000 staff across a decentralised and entrepreneurial network of 900 laboratories in over 50 countries. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Job Description: Job Summary: Conduct purification and analytical testing using large-scale lab equipment, while supporting lab operations, documentation, and cross-functional collaboration. Key Responsibilities: Protein purification Buffer preparation & formulation Column
-
People Operations Manager
Formation Bio - New York, NY; Boston, MAIndexed from Greenhouse Comp disclosed in posting2w agoWhy we showed this
Description: "inc"Description: "bio"+3
Unspecified Hr From the posting source - Mid From the posting source $122K-$155K From the posting source EquityPeople Operations Manager New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As People Operations Manager at Formation Bio, you will own the day-to-day operations that support our employees throughout their
-
Combination Welder - Austin Industrial Decatur, IL BIO
Austin Industries - Decatur, ILIndexed from Ukg Pro Benefit evidence checked Nov 20, 20261w agoWhy we showed this
Description: "inc"Description: "bio"+3
Unspecified Trades From the posting source - Mid From the posting source Salary not disclosed Inferred from posting 401(k) reportedCombination Welder - Austin Industrial Decatur, IL BIO Decatur, IL Austin Industrial Inc. is currently seeking an experienced Combination Welder to be based in Decatur, IL This position is not offering per diem, 5-8's, $21.22-$39.33per hour BIO
-
Millwright/Boilermaker Apprentice- Austin Industrial Decatur, IL BIO
Austin Industries - Decatur, ILIndexed from Ukg Pro Benefit evidence checked Nov 20, 2026 Comp disclosed in posting1w agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Trades From the posting source - Entry From the posting source $21.74-$37.26/hr From the posting source Inferred from posting 401(k) reportedMillwright/Boilermaker Apprentice- Austin Industrial Decatur, IL BIO Decatur, IL Austin Industrial, Inc. - is currently seeking an experienced Millwright to be based in Decatur, IL This position is not offering per diem, 5-8's, $21.74-$37.26 per hour. BIO Tank experience a plus
-
Engineering Manager, Infrastructure
Formation Bio - New York, NY; Boston, MA; San Francisco, CAIndexed from Greenhouse Comp disclosed in postingposted 81 days agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Engineering From the posting source - Mid From the posting source $186K-$232K From the posting source EquityEngineering Manager, Infrastructure New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As the Engineering Manager for Infrastructure at Formation Bio, you will lead the team responsible for
-
Senior Site Reliability Engineer
Formation Bio - New York, NY; Boston, MA; San Francisco, CAIndexed from Greenhouse Comp disclosed in postingposted 63 days agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Engineering From the posting source - Senior From the posting source $186K-$232K From the posting source EquitySenior Site Reliability Engineer New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Site Reliability Engineer at Formation Bio, you will build and operate the
-
Director, Financial Reporting
Formation Bio - New York, NY; Boston, MAIndexed from Greenhouse Comp disclosed in postingposted 91 days agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Finance From the posting source - Director Plus From the posting source $186K-$232K From the posting source EquityDirector, Financial Reporting New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is hiring a Director of Financial Reporting to lead financial reporting functions, prepare technical accounting analysis, lead
-
Director / Senior Director, DMPK
Formation Bio - Boston, MA; New York, NYIndexed from Greenhouse Comp disclosed in posting2w agoWhy we showed this
Description: "inc"Description: "bio"+3
Unspecified Other - Director Plus From the posting source $246K-$388K From the posting source EquityDirector / Senior Director, DMPK Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is seeking an experienced Director of Drug Metabolism and Pharmacokinetics (DMPK) to provide scientific and
-
Senior Data Engineer
Formation Bio - New York, NY; Boston, MA; San Francisco, CAIndexed from Greenhouse Comp disclosed in postingposted 63 days agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Data From the posting source - Senior From the posting source $186K-$232K From the posting source EquitySenior Data Engineer New York, NY; Boston, MA; San Francisco, CA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Data Engineer at Formation Bio, you will build the trusted data systems that
-
Senior Director of Asset Quality Assurance
Formation Bio - Boston, MA; New York, NYIndexed from Greenhouse Comp disclosed in postingposted 168 days agoWhy we showed this
Description: "inc"Description: "bio"+3
Unspecified Operations From the posting source - Director Plus From the posting source $178K-$232K From the posting source EquitySenior Director of Asset Quality Assurance Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is an AI native Biotech company running drug development programs, and the Quality function
-
Data Scientist, Medical Imaging (Open Level)
Formation Bio - Boston, MA; New York, NYIndexed from Greenhouse Comp disclosed in postingposted 30 days agoWhy we showed this
Description: "inc"Description: "bio"+3
Unspecified Data From the posting source - Mid From the posting source $178K-$232K From the posting source EquityData Scientist, Medical Imaging (Open Level) Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Senior Data Scientist - Medical Imaging at Formation Bio, you will lead our efforts
-
Data Scientist (Open Level)
Formation Bio - Boston, MA; New York, NYIndexed from Greenhouse Comp disclosed in postingposted 30 days agoWhy we showed this
Description: "bio"Description: "inc"+3
Unspecified Data From the posting source - Mid From the posting source $162K-$267K From the posting source EquityData Scientist (Open Level) Boston, MA; New York, NY About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position As a Data Scientist at Formation Bio, you will be at the forefront of revolutionizing drug development through
-
Vice President, Commercial Operations (Tumor HI Program)
Rezolute Inc - Redwood CityIndexed from Lever Comp disclosed in postingposted 171 days agoWhy we showed this
Description: semantic matchDescription: "bio"+3
Unspecified Sales From the posting source - Director Plus From the posting source $300K-$360K From the posting source Inferred from posting Learning budget Equity Unknown provenance 401(k) reportedVice President, Commercial Operations (Tumor HI Program) Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. Position Summary We are seeking a dynamic and experienced Vice President of Commercial Operations to establish and lead all operational aspects of our commercial strategy in support of the launch of our first rare disease therapy. This includes managing commercial operations functions ensuring the infrastructure, processes, and strategies necessary for successful product launch. This individual will be a strategic and hands-on leader responsible for building and managing critical commercial infrastructure, including sales operations, analytics, forecasting, market access operations, and commercial systems. This role oversees sales operations, forecasting and analytics, incentive compensation, market research, data management, CRM systems, field effectiveness, and commercial training. The ideal candidate has experience in rare disease or specialty pharmaceutical
Take this list with you
Download the 7 matching jobs in any format - read offline, archive, or hand to an AI assistant with your resume to find the best fits.
Or email it to me instead
The AI-ready prompt is a pre-written question you can paste into Claude, ChatGPT, Gemini, or Perplexity along with your resume. We never see your resume; this happens in your AI client of choice.
AI agent reading directly? Same data lives at /api/jobs.json?q=Korro+Bio+Inc.
See /llms.txt and /api/openapi.json for the full schema.